Marina Pellón-Consunji is a Board Member of Vibalogics since 2019. She is also a Partner at Ampersand Capital Partners, having joined in 2013. Prior to Ampersand, Marina was Associate Director in Healthcare Investment Banking at UBS where she worked on a number of leveraged buyouts, mergers and acquisitions, and debt and equity financings for middle market healthcare companies. Marina has deep life science investment expertise, and additionally has worked hands on within biochemistry laboratories at Harvard Medical School and Wellesley College. Marina’s current and past board seats include Gyros Protein Technologies, GeneWerk, Protagen, and Vibalogics. Marina holds a B.A. with Honors from Wellesley where she majored in Biological Chemistry and International Relations.